Long-Term Quality of Life After Ablation of Atrial Fibrillation: The Impact of Recurrence, Symptom Relief, and Placebo Effect
- 25 May 2010
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 55 (21), 2308-2316
- https://doi.org/10.1016/j.jacc.2010.01.040
Abstract
No abstract availableFunding Information
- Mayo Clinician Investigator Award
- BARD
- St. Jude Medical
- Medtronic
- Boston Scientific
- Pfizer
- National Institutes of Health, Medtronic, Inc.
- CryoCath
- Siemens AG
- EP Limited
- St. Jude Medical
- Minnesota Partnership for Biotechnology and Medical Genomics/University of Minnesota
- Biosense Webster, Inc.
- Boston Scientific
This publication has 21 references indexed in Scilit:
- Autonomic Elements within the Ligament of Marshall and Inferior Left Ganglionated Plexus Mediate Functions of the Atrial Neural NetworkJournal of Cardiovascular Electrophysiology, 2009
- Catheter Ablation Versus Antiarrhythmic Drugs for Atrial FibrillationCirculation, 2008
- Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic CardiomyopathyJournal of Cardiovascular Electrophysiology, 2008
- HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-UpA report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.EP Europace, 2007
- Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial FibrillationCirculation, 2006
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm SocietyJournal of the American College of Cardiology, 2006
- Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial FibrillationCirculation, 2005
- Quality of life in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyAmerican Heart Journal, 2005
- Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial isolationAmerican Heart Journal, 2004
- Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic functionJournal of the American College of Cardiology, 2004